Management of Mild Hyponatremia (Serum Sodium 131 mmol/L)
For a patient with serum sodium of 131 mmol/L, the appropriate management depends critically on symptom severity and volume status; asymptomatic or mildly symptomatic patients require investigation of the underlying cause, assessment of volume status (hypovolemic, euvolemic, or hypervolemic), and targeted treatment based on these findings—not emergent hypertonic saline. 1
Initial Assessment and Workup
Hyponatremia at 131 mmol/L warrants full diagnostic evaluation including serum and urine osmolality, urine sodium concentration, urine electrolytes, serum uric acid, and careful assessment of extracellular fluid volume status. 1 This level sits just below the threshold where comprehensive investigation is recommended (sodium <131 mmol/L), though even mild hyponatremia (130-135 mmol/L) should not be dismissed as clinically insignificant. 1, 2
Key Diagnostic Tests
- Serum osmolality to confirm hypotonic hyponatremia and exclude pseudohyponatremia 1
- Urine osmolality and urine sodium to differentiate between SIADH, hypovolemic causes, and hypervolemic states 1
- Serum uric acid <4 mg/dL has 73-100% positive predictive value for SIADH 1
- Thyroid function (TSH) and morning cortisol to exclude hypothyroidism and adrenal insufficiency 1
Do not obtain plasma ADH or natriuretic peptide levels—these tests are not supported by evidence, delay diagnosis, and do not alter management. 1
Treatment Based on Volume Status
Hypovolemic Hyponatremia
Administer isotonic saline (0.9% NaCl) for volume repletion at an initial rate of 15-20 mL/kg/h, then 4-14 mL/kg/h based on clinical response. 1 Discontinue any diuretics immediately if sodium is <125 mmol/L. 1 A urine sodium <30 mmol/L predicts good response to saline infusion with 71-100% positive predictive value. 1
Euvolemic Hyponatremia (SIADH)
Fluid restriction to 1 L/day is the cornerstone of treatment for SIADH. 1 If fluid restriction fails after 24-48 hours, add oral sodium chloride 100 mEq three times daily. 1 For resistant cases, consider pharmacological options including urea, loop diuretics, demeclocycline, or vasopressin receptor antagonists (tolvaptan 15 mg once daily, titrated to 30-60 mg). 1, 3
Hypervolemic Hyponatremia (Heart Failure, Cirrhosis)
Implement fluid restriction to 1-1.5 L/day for sodium <125 mmol/L. 1 In cirrhotic patients, consider albumin infusion (8 g per liter of ascites removed) alongside fluid restriction. 1 Avoid hypertonic saline unless life-threatening symptoms develop, as it worsens ascites and edema. 1
Critical Correction Rate Guidelines
The maximum correction rate must not exceed 8 mmol/L in any 24-hour period to prevent osmotic demyelination syndrome. 1, 3 For standard-risk patients, target 4-8 mmol/L per day. 1
High-risk patients require even slower correction (4-6 mmol/L per day, maximum 8 mmol/L in 24 hours), including those with: 1
- Advanced liver disease or cirrhosis
- Chronic alcoholism
- Malnutrition
- Prior hepatic encephalopathy
- Severe hyponatremia (<120 mmol/L)
Special Considerations
Neurosurgical Patients
In patients with acute brain injury, distinguish between SIADH (euvolemic) and cerebral salt wasting (hypovolemic) as they require opposite treatments. 1 CSW requires volume and sodium replacement with isotonic or hypertonic saline, while SIADH requires fluid restriction. 1 Never use fluid restriction in cerebral salt wasting—this worsens outcomes and can precipitate cerebral ischemia. 1
Patients on Diuretics
For sodium 126-135 mmol/L with normal renal function, continue diuretic therapy but monitor serum electrolytes closely; water restriction is not recommended at this level. 1 If sodium drops below 125 mmol/L, discontinue diuretics and consider volume expansion for hypovolemic patients or fluid restriction for hypervolemic patients. 1
Clinical Significance of Mild Hyponatremia
Even at 131 mmol/L, hyponatremia is associated with increased morbidity. 2, 4 Mild chronic hyponatremia (130-135 mmol/L) causes: 2, 4
- Cognitive impairment and altered memory
- Gait instability and increased fall risk (21% vs 5% in normonatremic patients)
- 60-fold increased hospital mortality risk when sodium <130 mmol/L (11.2% vs 0.19%)
In cirrhotic patients, sodium ≤130 mmol/L increases risk of spontaneous bacterial peritonitis (OR 3.40), hepatorenal syndrome (OR 3.45), and hepatic encephalopathy (OR 2.36). 1
Common Pitfalls to Avoid
- Never correct chronic hyponatremia faster than 8 mmol/L in 24 hours—this causes osmotic demyelination syndrome characterized by dysarthria, dysphagia, oculomotor dysfunction, and quadriparesis 2-7 days after overcorrection. 1, 3
- Do not use hypertonic saline for asymptomatic or mildly symptomatic hyponatremia at 131 mmol/L—reserve this for severe symptomatic hyponatremia with altered mental status, seizures, or coma. 1, 5
- Avoid fluid restriction in hypovolemic states or cerebral salt wasting—this worsens outcomes. 1
- Do not ignore mild hyponatremia as clinically insignificant—it requires investigation and appropriate management. 1, 2
Monitoring During Treatment
- Check serum sodium every 24-48 hours initially during correction 1
- Monitor for signs of osmotic demyelination syndrome (typically 2-7 days after rapid correction): dysarthria, dysphagia, oculomotor dysfunction, quadriparesis 1
- Assess volume status regularly through physical examination, orthostatic vital signs, and clinical response 1